NeoGenomics Statistics
Share Statistics
NeoGenomics has 128.36M shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 128.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.16% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 126.84M |
| Failed to Deliver (FTD) Shares | 930 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 3.92M, so 3.05% of the outstanding shares have been sold short.
| Short Interest | 3.92M |
| Short % of Shares Out | 3.05% |
| Short % of Float | 3.09% |
| Short Ratio (days to cover) | 6.78 |
Valuation Ratios
The PE ratio is -23.08 and the forward PE ratio is 81.65.
| PE Ratio | -23.08 |
| Forward PE | 81.65 |
| PS Ratio | 3.43 |
| Forward PS | 2.7 |
| PB Ratio | 2.16 |
| P/FCF Ratio | -66.13 |
| PEG Ratio | n/a |
Enterprise Valuation
NeoGenomics Inc. has an Enterprise Value (EV) of 2.30B.
| EV / Earnings | -26.14 |
| EV / Sales | 3.89 |
| EV / EBITDA | -130.62 |
| EV / EBIT | -21.35 |
| EV / FCF | -74.9 |
Financial Position
The company has a current ratio of 6.2, with a Debt / Equity ratio of 0.57.
| Current Ratio | 6.2 |
| Quick Ratio | 5.95 |
| Debt / Equity | 0.57 |
| Total Debt / Capitalization | 36.37 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -15.6 |
Financial Efficiency
Return on equity (ROE) is -0.09% and return on capital (ROIC) is -6.28%.
| Return on Equity (ROE) | -0.09% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -6.28% |
| Revenue Per Employee | 281.73K |
| Profits Per Employee | -41.89K |
| Employee Count | 2.10K |
| Asset Turnover | 0.35 |
| Inventory Turnover | 14.37 |
Taxes
| Income Tax | -9.13M |
| Effective Tax Rate | 0.09 |
Stock Price Statistics
The stock price has increased by 8.78% in the last 52 weeks. The beta is 1.18, so NeoGenomics 's price volatility has been higher than the market average.
| Beta | 1.18 |
| 52-Week Price Change | 8.78% |
| 50-Day Moving Average | 16.18 |
| 200-Day Moving Average | 15.14 |
| Relative Strength Index (RSI) | 51.71 |
| Average Volume (20 Days) | 745.20K |
Income Statement
In the last 12 months, NeoGenomics had revenue of 591.64M and earned -87.97M in profits. Earnings per share was -0.7.
| Revenue | 591.64M |
| Gross Profit | 244.60M |
| Operating Income | -107.74M |
| Net Income | -87.97M |
| EBITDA | -17.61M |
| EBIT | -107.74M |
| Earnings Per Share (EPS) | -0.7 |
Balance Sheet
The company has 342.49M in cash and 611.68M in debt, giving a net cash position of -269.19M.
| Cash & Cash Equivalents | 342.49M |
| Total Debt | 611.68M |
| Net Cash | -269.19M |
| Retained Earnings | -247.06M |
| Total Assets | 1.64B |
| Working Capital | 293.83M |
Cash Flow
In the last 12 months, operating cash flow was -1.95M and capital expenditures -28.75M, giving a free cash flow of -30.70M.
| Operating Cash Flow | -1.95M |
| Capital Expenditures | -28.75M |
| Free Cash Flow | -30.70M |
| FCF Per Share | -0.24 |
Margins
Gross margin is 4.13K%, with operating and profit margins of -1.82K% and -1.49K%.
| Gross Margin | 4.13K% |
| Operating Margin | -1.82K% |
| Pretax Margin | -1.64K% |
| Profit Margin | -1.49K% |
| EBITDA Margin | -2.98% |
| EBIT Margin | -18.21% |
| FCF Margin | -5.19% |
Dividends & Yields
NEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.12% |
| FCF Yield | -1.41% |
Analyst Forecast
The average price target for NEO is $19, which is 11.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $19 |
| Price Target Difference | 11.9% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
The last stock split was on Apr 16, 2003. It was a backward split with a ratio of 1:100.
| Last Split Date | Apr 16, 2003 |
| Split Type | backward |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | 2 |
| Piotroski F-Score | 5 |